BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Genetown

  No Chemicals, Heat or Irradiation Needed for Aphios’ Viral Inactivation Tech

  Aphios International is developing a generally applicable pathogen reduction technology for pooled blood plasma and blood products, immunoglobulins, recombinant biologics and monoclonal antibodies used to treat cancer and COVID-19 patients.

  May 13, 2021

   · 

  4 min read

   · 

  Gail Dutton
• 

  Drug Development

  Israeli Company Grabs $28.5 Million for Restorative Cystic Fibrosis Treatment

  SpliSense, which focuses on cystic fibrosis and other genetic pulmonary diseases, closed on a $28.5 million Series B financing round. The company plans to use the money to advance its pipeline.

  May 13, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Job Trends

  Third Rock Ventures Launches Flare Therapeutics With $82 Million Series A

  Significant contributions were made to the Series A by Boxer Capital, Nextech Invest, Casdin Capital, Invus Financial Advisors, and Eventide Asset Management.

  May 13, 2021

   · 

  2 min read

   · 

  Brandon May
• 

  Business

  Emergent Bio Execs to Testify Before Congress Following Vaccine Manufacturing Mistake

  Emergent company executives Fuad El-ibri and Robert Kramer will be testifying before a congressional probe after a botched batch of 15 million doses of J&J’s COVID-19 vaccine.

  May 13, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  FDA

  Heron Wins Approval for Non-Opioid Drug, Allay Therapeutics Launches in Pain Management Space

  Shares of Heron Therapeutics climbs after it announced the U.S. FDA approved its non-opioid drug for extended pain relief following some surgeries.

  May 13, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Rare Disease Companies Unite to Advocate for Life-Changing Therapies

  The Rare Disease Company Coalition’s 10 founding members have brought 22 treatments to market and currently have more than 160 rare disease programs in the works.

  May 13, 2021

   · 

  4 min read

   · 

  Kate Goodwin
• 

  FDA

  Merck’s Blockbuster Keytruda Tries Again with New Data for TNBC Approval

  Merck announced positive results from the late-stage KEYNOTE-522 study that should support its previous attempt that was stymied by a regulatory advisory committee in February and rejected by the U.S. FDA in March.

  May 13, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Biotech Bay

  Research Roundup: Neuronal Cell Death in Alzheimer’s and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  May 13, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  FDA

  The Latest News in the Battle Against COVID-19

  There was a lot of news and research studies today related to the COVID-19 vaccines. Here’s a look.

  May 13, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Career Advice

  Do You Need an Advanced Degree in Your Field? If So, Which One?

  We’ll answer these questions and a few others here in order to help you determine which path best fits your needs for the future of your biotech career.

  May 13, 2021

   · 

  3 min read

   · 

  Kymberlie Krieger